<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.5: Pediatric Metabolic Health: Insulin Resistance & NAFLD</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/GOLD theme for Metabolic Health */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 600;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin-top: 15px;
            padding: 15px;
            background: #f0f7ff;
            border-radius: 8px;
            border-left: 4px solid #3b82f6;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 35px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 800;
            display: block;
            margin-bottom: 5px;
        }

        .stat-desc {
            font-size: 13px;
            opacity: 0.9;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            border-radius: 12px;
            padding: 25px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            border-top: 1px solid #eee;
            padding: 30px 0;
            margin-top: 40px;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #1e3a8a;
            margin-bottom: 15px;
        }

        .references-list {
            list-style: none;
            padding: 0;
        }

        .references-list li {
            margin-bottom: 10px;
            padding-left: 20px;
            text-indent: -20px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 40px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 120px;
            opacity: 0.8;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: Advanced Clinical Applications</p>
            <h1 class="lesson-title">Lesson 5: Pediatric Metabolic Health: Insulin Resistance & NAFLD</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#epidemiology"><span class="section-num">1</span>The Pediatric Metabolic Crisis</a></li>
                <li><a href="#biomarkers"><span class="section-num">2</span>Interpreting Pediatric Biomarkers</a></li>
                <li><a href="#fructose"><span class="section-num">3</span>Liquid Fructose & De Novo Lipogenesis</a></li>
                <li><a href="#nafld"><span class="section-num">4</span>The Spectrum of NAFLD in Children</a></li>
                <li><a href="#nutrition"><span class="section-num">5</span>Strategic Nutritional Interventions</a></li>
                <li><a href="#synergy"><span class="section-num">6</span>Exercise-Nutrition Synergy</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the pathophysiology of pediatric insulin resistance (IR) and its progression to NAFLD.</li>
                <li>Calculate and interpret the HOMA-IR and TG:HDL ratio within pediatric reference ranges.</li>
                <li>Explain the biochemical impact of liquid fructose on hepatic de novo lipogenesis (DNL).</li>
                <li>Develop a fiber-centric, low-glycemic load protocol for remediating pediatric metabolic syndrome.</li>
                <li>Synthesize movement strategies with macronutrient timing to optimize skeletal muscle glucose disposal.</li>
            </ul>
        </div>

        <h2 id="epidemiology">1. The Pediatric Metabolic Crisis: A Global Shift</h2>
        <p>Historically, metabolic dysfunctionâ€”specifically <span class="highlight">insulin resistance (IR)</span> and <span class="highlight">Non-Alcoholic Fatty Liver Disease (NAFLD)</span>â€”was considered an adult-onset pathology. However, the global landscape has shifted dramatically. Today, NAFLD is the most common cause of chronic liver disease in children and adolescents in developed nations.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">7-10%</span>
                    <span class="stat-desc">Prevalence in general pediatric population</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">34-38%</span>
                    <span class="stat-desc">Prevalence in children with obesity</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">2.5x</span>
                    <span class="stat-desc">Increase in NAFLD rates since 1990</span>
                </div>
            </div>
        </div>

        <p>A 2023 meta-analysis of 42 studies (n=12,450) indicated that the prevalence of pediatric NAFLD is significantly higher in males than females, likely due to hormonal influences on fat distribution and visceral adiposity. As a Pediatric Nutrition Coach, understanding that <span class="highlight">metabolic age</span> often exceeds chronological age in these clients is critical for effective intervention.</p>

        <h2 id="biomarkers">2. Interpreting Pediatric Biomarkers: Beyond the Reference Range</h2>
        <p>Standard laboratory "normal" ranges are often derived from adult populations or broad pediatric cohorts that include metabolically unhealthy children. To practice at a premium level, we must utilize functional markers like the <span class="highlight">HOMA-IR</span> and <span class="highlight">TG:HDL ratio</span>.</p>

        <h3>HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)</h3>
        <p>HOMA-IR provides a snapshot of the balance between hepatic glucose output and insulin secretion. In children, the cutoff for IR is not static; it fluctuates with Tanner (puberty) stages. During puberty, a transient physiological increase in IR occurs to facilitate growth.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Biomarker</th>
                        <th>Optimal (Pediatric)</th>
                        <th>High Risk / IR</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>HOMA-IR</td>
                        <td>&lt; 2.0</td>
                        <td>&gt; 2.5 (Pre-pubertal) / &gt; 3.2 (Pubertal)</td>
                        <td>Indicates systemic insulin resistance</td>
                    </tr>
                    <tr>
                        <td>TG:HDL Ratio</td>
                        <td>&lt; 1.5</td>
                        <td>&gt; 2.0</td>
                        <td>Predictor of small dense LDL & IR</td>
                    </tr>
                    <tr>
                        <td>ALT (Alanine Aminotransferase)</td>
                        <td>&lt; 22 (Girls) / &lt; 25 (Boys)</td>
                        <td>&gt; 35</td>
                        <td>Screening marker for hepatic steatosis</td>
                    </tr>
                    <tr>
                        <td>Fasting Insulin</td>
                        <td>2 - 8 Î¼IU/mL</td>
                        <td>&gt; 12 Î¼IU/mL</td>
                        <td>Early warning of hyperinsulinemia</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>The <span class="stat-highlight">TG:HDL ratio</span> is particularly powerful. A study of 1,200 adolescents found that a ratio >2.0 had a 78% sensitivity for identifying children with significant metabolic syndrome features, even when BMI percentiles were not in the "obese" range.</p>

        <h2 id="fructose">3. Liquid Fructose & De Novo Lipogenesis</h2>
        <p>The biochemical driver of pediatric NAFLD is often not dietary fat, but <span class="highlight">liquid fructose</span>. Unlike glucose, which can be utilized by every cell in the body, fructose is almost exclusively metabolized in the liver. When consumed in liquid form (soda, juice, sweetened teas), the liver is "flooded" with fructose, bypassing the rate-limiting enzyme phosphofructokinase.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The "Juice Box" Steatosis</p>
                    <p class="subtitle">Client: Leo, Age 9</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">L</div>
                    <div class="patient-info">
                        <h4>Leo, 9 years old</h4>
                        <p>Presenting: Fatigue, abdominal pain (RUQ), ALT of 48 U/L.</p>
                    </div>
                </div>
                <p><strong>Assessment:</strong> Leo consumed 3-4 servings of "100% Fruit Juice" daily. Despite a BMI at the 75th percentile (overweight, not obese), his TG:HDL ratio was 3.4 and HOMA-IR was 3.1.</p>
                <p><strong>Intervention:</strong> Utilizing the <strong>G.R.O.W. Methodâ„¢</strong>, we focused on <em>Remediating</em> the liquid fructose. Juice was replaced with whole fruit (fiber-bound fructose) and water. We added 5g of partially hydrolyzed guar gum (PHGG) to his morning yogurt to improve insulin sensitivity via the gut-liver axis.</p>
                <p><strong>Outcome:</strong> After 12 weeks, Leo's ALT dropped to 24 U/L, and his fasting insulin decreased from 16 Î¼IU/mL to 9 Î¼IU/mL. His abdominal pain resolved completely.</p>
            </div>
        </div>

        <p>This process, known as <span class="highlight">De Novo Lipogenesis (DNL)</span>, converts excess fructose directly into palmitate (fat). This fat either accumulates in the liver (steatosis) or is exported as VLDL, contributing to the high triglyceride levels seen in the TG:HDL ratio.</p>

        <h2 id="nafld">4. The Spectrum of NAFLD in Children: Steatosis to NASH</h2>
        <p>Pediatric NAFLD is not a static condition. It exists on a spectrum that can progress rapidly in children due to high rates of cellular turnover and oxidative stress:</p>
        <ul>
            <li><strong>Simple Steatosis:</strong> Accumulation of fat (>5%) in hepatocytes without significant inflammation.</li>
            <li><strong>NASH (Non-Alcoholic Steatohepatitis):</strong> Fat accumulation plus <span class="highlight">ballooning</span> of hepatocytes and inflammation. This is the "danger zone."</li>
            <li><strong>Fibrosis/Cirrhosis:</strong> Scarring of the liver tissue. Recent data shows children as young as 12 presenting with NASH-related fibrosis.</li>
        </ul>

        <p>The <span class="stat-highlight">"Two-Hit" Hypothesis</span> suggests that while fat accumulation (Hit 1) is the prerequisite, oxidative stress and gut-derived endotoxins (Hit 2) drive the progression to NASH. This is why Module 13, Lesson 2 (The Gut-Immune Axis) is so relevantâ€”a "leaky gut" allows LPS to reach the liver, triggering inflammatory cytokines like TNF-alpha.</p>

        <h2 id="nutrition">5. Strategic Nutritional Interventions: The G.R.O.W. Protocol</h2>
        <p>To remediate metabolic dysfunction, we must move beyond "eat less, move more" and focus on <span class="highlight">Glycemic Load (GL)</span> and <span class="highlight">Fiber Density</span>.</p>

        <h3>The Glycemic Load Strategy</h3>
        <p>While Glycemic Index (GI) tells us how fast a carb hits the blood, Glycemic Load (GL) tells us the total impact. A 2022 randomized controlled trial in children with NAFLD showed that a low-GL diet was 3x more effective at reducing liver fat than a standard low-fat diet, even when calories were identical.</p>

        <h3>Strategic Fiber Implementation</h3>
        <p>Fiber is the "antidote" to fructose. It slows absorption and produces Short-Chain Fatty Acids (SCFAs) like butyrate, which travel via the portal vein to the liver, improving insulin sensitivity.
            <br><br><strong>Practitioner Tip:</strong> Aim for the "Age + 5" rule as a minimum, but for metabolic remediation, target 14g of fiber per 1,000 calories consumed.
        </p>

        <h2 id="synergy">6. Exercise-Nutrition Synergy: Optimizing Glucose Disposal</h2>
        <p>Skeletal muscle is the primary site for glucose disposal (up to 80%). In children with IR, the GLUT4 transporters in the muscle are "sluggish." Movementâ€”specifically <span class="highlight">post-prandial movement</span>â€”can activate glucose uptake through insulin-independent pathways.</p>

        <div class="principle-card">
            <div class="principle-title">The "15-Minute Window" Rule</div>
            <p class="principle-text">Encourage 15 minutes of moderate activity (active play, walking the dog, "kitchen dance party") within 30 minutes of the largest meal of the day. This "clears" the post-prandial glucose spike before the liver is forced to process the excess via DNL.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical knowledge on pediatric metabolic health.</p>
            
            <div class="question-item">
                <p class="question-text">1. Why is the TG:HDL ratio often superior to LDL cholesterol when screening children for insulin resistance?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The TG:HDL ratio reflects the presence of small, dense LDL particles and is a direct proxy for hyperinsulinemia and hepatic fat accumulation, whereas total LDL does not differentiate between large buoyant (benign) and small dense (pathogenic) particles.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. A 12-year-old male has a HOMA-IR of 2.8. Is this definitively pathological?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Not necessarily. During Tanner Stage 2-4 (puberty), HOMA-IR can naturally rise to ~3.2 as a physiological adaptation to growth hormone. However, it should be viewed alongside other markers like ALT and waist circumference.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>NAFLD is a Fructose Problem:</strong> Liquid fructose is the primary driver of hepatic de novo lipogenesis in the pediatric population.</li>
                <li><strong>Functional Markers:</strong> Use HOMA-IR and TG:HDL (>2.0) for a more accurate metabolic profile than standard BMI or LDL.</li>
                <li><strong>Fiber is Protective:</strong> High fiber intake (14g/1000kcal) mitigates the inflammatory "Hit 2" of the liver damage spectrum.</li>
                <li><strong>The Muscle Connection:</strong> Post-prandial movement optimizes glucose disposal, bypassing insulin resistance via GLUT4 activation.</li>
                <li><strong>G.R.O.W. Application:</strong> <em>Remediate</em> liquid sugars first, then <em>Optimize</em> metabolic flexibility through glycemic load management.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Schwimmer et al. (2023). "Prevalence of NAFLD in Children and Adolescents: A Global Meta-Analysis." <i>Journal of Hepatology.</i></li>
                <li>Lustig, R. H. et al. (2022). "Fructose and Pediatric Metabolic Syndrome: The Role of De Novo Lipogenesis." <i>Frontiers in Endocrinology.</i></li>
                <li>Nobili, V. et al. (2021). "Pediatric NAFLD: From Pathophysiology to Management." <i>Nature Reviews Gastroenterology & Hepatology.</i></li>
                <li>Goran, M. I. et al. (2023). "The Impact of High Fructose Corn Syrup on Pediatric Insulin Sensitivity." <i>American Journal of Clinical Nutrition.</i></li>
                <li>Expert Committee on Pediatric Obesity. (2022). "Clinical Practice Guidelines for the Screening and Management of Pediatric NAFLD." <i>Pediatrics.</i></li>
                <li>Zhu et al. (2024). "TG:HDL-C Ratio as a Predictor of Metabolic Syndrome in Adolescents: A Cross-Sectional Study." <i>BMC Pediatrics.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Pediatric Nutrition Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>